InnovaRx Innova Health Strategies
Pricing Sign in

Neuroendocrine Tumors

MeSH D018358

A MeSH concept, not an ICD-10 code. It usually spans several ICD-10 codes.

Contraindicated with · 49

albiglutide atomoxetine atomoxetine hydrochloride carbidopa carbidopa anhydrous dasiglucagon dopamine dopamine hydrochloride doxapram doxapram hydrochloride dulaglutide glucagon glucagon hydrochloride glucagon (rDNA) guanadrel guanadrel sulfate guanethidine guanethidine monosulfate guanethidine sulfate iothalamate iothalamate meglumine iothalamate sodium I125 isocarboxazid levodopa meglumine iodipamide methoxsalen metoclopramide metoclopramide dihydrochloride metoclopramide hydrochloride midodrine midodrine hydrochloride minoxidil minoxidil sulfate minoxidil sulfate ester opicapone orforglipron orforglipron calcium phenelzine phenelzine sulfate propiomazine propiomazine hydrochloride ritodrine ritodrine hydrochloride semaglutide sodium iothalamate tirzepatide tranylcypromine tranylcypromine sulfate trioxsalen

Indicated for · 65

aldesleukin atezolizumab atezolizumab-tqjs avelumab berahyaluronidase alfa berahyaluronidase alfa-pmph binimetinib bleomycin bleomycin sulfate carmustine cisplatin cobimetinib cobimetinib fumarate dabrafenib dabrafenib mesylate dacarbazine dactinomycin docetaxel docetaxel anhydrous encorafenib herpesvirus 1, human hydroxyurea interferon alfa-2a interferon alfa-2b interferon alfa-3n,human leukocyte derived interferon alfacon-1 interferon gamma-1b iobenguane I-131 ipilimumab lanreotide lanreotide acetate lifileucel lomustine lutetium Lu 177 dotatate metyrosine nivolumab nivolumab-nvhy nivolumab-rmbw peginterferon alfa-2a peginterferon alfa-2b pembrolizumab pembrolizumab-pmph phenoxybenzamine phenoxybenzamine hydrochloride procarbazine procarbazine hydrochloride propranolol propranolol hydrochloride recombinant interferon beta-1b relatlimab relatlimab-rmbw retifanlimab retifanlimab-dlwr sunitinib sunitinib malate talimogene laherparepvec tebentafusp tebentafusp-tebn telotristat telotristat ethyl telotristat etiprate temozolomide trametinib trametinib dimethyl sulfoxide vemurafenib